134 related articles for article (PubMed ID: 21476495)
41. Effects of ligands or substrate of insulin-regulated aminopeptidase (IRAP) on trophoblast invasion.
Cohen M; Wuillemin C; Chai SY; Bischof P
J Pept Sci; 2008 Jul; 14(7):883-7. PubMed ID: 18275097
[TBL] [Abstract][Full Text] [Related]
42. Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP.
Wallis MG; Lankford MF; Keller SR
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1092-102. PubMed ID: 17684103
[TBL] [Abstract][Full Text] [Related]
43. The insulin-regulated aminopeptidase IRAP is colocalised with GLUT4 in the mouse hippocampus--potential role in modulation of glucose uptake in neurones?
Fernando RN; Albiston AL; Chai SY
Eur J Neurosci; 2008 Aug; 28(3):588-98. PubMed ID: 18702730
[TBL] [Abstract][Full Text] [Related]
44. Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.
Borthwick AD; Davies DE; Ertl PF; Exall AM; Haley TM; Hart GJ; Jackson DL; Parry NR; Patikis A; Trivedi N; Weingarten GG; Woolven JM
J Med Chem; 2003 Oct; 46(21):4428-49. PubMed ID: 14521407
[TBL] [Abstract][Full Text] [Related]
45. Structure-based design and synthesis of macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors.
Machauer R; Veenstra S; Rondeau JM; Tintelnot-Blomley M; Betschart C; Neumann U; Paganetti P
Bioorg Med Chem Lett; 2009 Mar; 19(5):1361-5. PubMed ID: 19195886
[TBL] [Abstract][Full Text] [Related]
46. Effects of some new angiotensin II analogs on the reactivity of small arterioles in the mesentery of rat intestine.
Folwarczna J; Janiec W; Sliwiński L; Paruszewski R
Pol J Pharmacol Pharm; 1989; 41(6):585-9. PubMed ID: 2485905
[TBL] [Abstract][Full Text] [Related]
47. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
Dutta AS; Crowther M; Gormley JJ; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Jamieson A; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
J Pept Sci; 2000 Jul; 6(7):321-41. PubMed ID: 10946997
[TBL] [Abstract][Full Text] [Related]
48. Aryl Sulfonamide Inhibitors of Insulin-Regulated Aminopeptidase Enhance Spine Density in Primary Hippocampal Neuron Cultures.
Diwakarla S; Nylander E; Grönbladh A; Vanga SR; Shamsudin Y; Gutiérrez-de-Terán H; Sävmarker J; Ng L; Pham V; Lundbäck T; Jenmalm-Jensen A; Svensson R; Artursson P; Zelleroth S; Engen K; Rosenström U; Larhed M; Åqvist J; Chai SY; Hallberg M
ACS Chem Neurosci; 2016 Oct; 7(10):1383-1392. PubMed ID: 27501164
[TBL] [Abstract][Full Text] [Related]
49. Sub-cellular localization of insulin-regulated membrane aminopeptidase, IRAP to vesicles in neurons.
Fernando RN; Luff SE; Albiston AL; Chai SY
J Neurochem; 2007 Aug; 102(3):967-76. PubMed ID: 17504262
[TBL] [Abstract][Full Text] [Related]
50. Identification of modulating residues defining the catalytic cleft of insulin-regulated aminopeptidase.
Ye S; Chai SY; Lew RA; Ascher DB; Morton CJ; Parker MW; Albiston AL
Biochem Cell Biol; 2008 Jun; 86(3):251-61. PubMed ID: 18523486
[TBL] [Abstract][Full Text] [Related]
51. Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).
Zhang YM; Fan X; Yang SM; Scannevin RH; Burke SL; Rhodes KJ; Jackson PF
Bioorg Med Chem Lett; 2008 Jan; 18(1):405-8. PubMed ID: 17980583
[TBL] [Abstract][Full Text] [Related]
52. Design and synthesis of potent macrocyclic renin inhibitors.
Sund C; Belda O; Wiktelius D; Sahlberg C; Vrang L; Sedig S; Hamelink E; Henderson I; Agback T; Jansson K; Borkakoti N; Derbyshire D; Eneroth A; Samuelsson B
Bioorg Med Chem Lett; 2011 Jan; 21(1):358-62. PubMed ID: 21112780
[TBL] [Abstract][Full Text] [Related]
53. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
[TBL] [Abstract][Full Text] [Related]
54. Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs.
Bäck M; Johansson PO; Wångsell F; Thorstensson F; Kvarnström I; Ayesa S; Wähling H; Pelcman M; Jansson K; Lindström S; Wallberg H; Classon B; Rydergård C; Vrang L; Hamelink E; Hallberg A; Rosenquist S; Samuelsson B
Bioorg Med Chem; 2007 Nov; 15(22):7184-202. PubMed ID: 17845856
[TBL] [Abstract][Full Text] [Related]
55. Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).
Li X; Wang Y; Wu J; Li Y; Wang Q; Xu W
Bioorg Med Chem; 2009 Apr; 17(8):3061-71. PubMed ID: 19339187
[TBL] [Abstract][Full Text] [Related]
56. Phenylalanine-544 plays a key role in substrate and inhibitor binding by providing a hydrophobic packing point at the active site of insulin-regulated aminopeptidase.
Albiston AL; Pham V; Ye S; Ng L; Lew RA; Thompson PE; Holien JK; Morton CJ; Parker MW; Chai SY
Mol Pharmacol; 2010 Oct; 78(4):600-7. PubMed ID: 20628006
[TBL] [Abstract][Full Text] [Related]
57. Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).
Li X; Wang J; Li J; Wu J; Li Y; Zhu H; Fan R; Xu W
Bioorg Med Chem; 2009 Apr; 17(8):3053-60. PubMed ID: 19329328
[TBL] [Abstract][Full Text] [Related]
58. Therapeutic targeting of insulin-regulated aminopeptidase: heads and tails?
Albiston AL; Peck GR; Yeatman HR; Fernando R; Ye S; Chai SY
Pharmacol Ther; 2007 Dec; 116(3):417-27. PubMed ID: 17900701
[TBL] [Abstract][Full Text] [Related]
59. Discovery of novel aldose reductase inhibitors characterized by an alkoxy-substituted phenylacetic acid core.
Rakowitz D; Gmeiner A; Matuszczak B
Arch Pharm (Weinheim); 2006 Oct; 339(10):559-63. PubMed ID: 17009300
[TBL] [Abstract][Full Text] [Related]
60. A phosphonamidate containing aromatic N-terminal amino group as inhibitor of leucine aminopeptidase-design, synthesis and stability.
Mucha A; Kunert A; Grembecka J; Pawełczak M; Kafarski P
Eur J Med Chem; 2006 Jun; 41(6):768-72. PubMed ID: 16690170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
